From the aspects of clinical experience and current indications, randomized clinical trials and new evidence-based methodologies to the prospective clinical databases and collaborative networks, the authors suggested that particle therapy holds great promise to improve the therapeutic outcome of cancer patients treated with this modality, however, there is an urgency to produce high quality clinical evidence.

The collaboration across institutions and countries is needed to secure evidence-based implementation of particle therapy.